Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease diabetes mellitus, insulin-dependent
Symptom C0020598|hypoglycaemia
Sentences 47
PubMedID- 25053672 Recurrent hypoglycaemia in a patient with type 1 diabetes.
PubMedID- 22047939 Aim: this study examines whether the short-term use of a continuous glucose monitor (cgm) can reduce the fear of hypoglycaemia in individuals with type 1 diabetes mellitus (t1dm).
PubMedID- 21323815 Improvements in real-time continuous glucose monitoring and optimisation of basal insulin dosing may offer significant benefit to preventing hypoglycaemia in patients with type 1 diabetes who regularly exercise.
PubMedID- 24057153 Using ideg, insulin-naive and insulin-treated patients with type 2 diabetes showed a significantly reduced risk of overall and nocturnal hypoglycaemia events .
PubMedID- 25683747 Conclusions: a weight-based protocol of 0.3 g/kg glucose appears more effective for treating symptomatic hypoglycaemia in adults with type 1 diabetes than either the most common current recommendation of 15 g glucose or a 0.2 g/kg glucose dose.
PubMedID- 25764474 Fear of hypoglycaemia in adults with type 1 diabetes: results from diabetes miles - the netherlands.
PubMedID- 24965522 Conclusions: in addition to the classic physical symptoms experienced during hypoglycaemia, adolescents with type 1 diabetes report psychosensorial, mood and behavioral symptoms, and some describe them as positive experiences.
PubMedID- 23266467 Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way.
PubMedID- 22727048 Graphic presentation of the hypoana study which is a prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia.
PubMedID- 26044206 The current result might be related to a lower frequency of nocturnal hypoglycaemia in individuals with type 1 diabetes who use ideg as basal insulin .
PubMedID- 24023652 These findings agree with the results of previous studies where the neuroendocrine response of vasopressin to hypoglycaemia was enhanced in patients with type 1 diabetes compared to healthy subjects.
PubMedID- 26173655 Effects of acute caffeine supplementation on reducing exercise-associated hypoglycaemia in individuals with type 1 diabetes mellitus.
PubMedID- 21309845 Frequency of symptomatic and asymptomatic hypoglycaemia in type 1 diabetes: effect of impaired awareness of hypoglycaemia.
PubMedID- 25694217 Aims: to assess whether the dipeptidyl peptidase-4 (dpp-4) inhibitor sitagliptin affects glucagon and other counter-regulatory hormone responses to hypoglycaemia in patients with type 1 diabetes.
PubMedID- 23121373 Disrupted performance in simulated driving has been demonstrated during hypoglycaemia in people with type 1 diabetes .
PubMedID- 24320159 Are bedtime nutritional strategies effective in preventing nocturnal hypoglycaemia in patients with type 1 diabetes.
PubMedID- 22371161 Continuous subcutaneous insulin infusion (csii, or insulin pump therapy) reduces hba1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (t1dm) compared with multiple daily insulin injections (mdi).
PubMedID- 20132542 We have no clear explanation why our results indicate a lower impact on hrqol of fear of hypoglycaemia in individuals with type 1 diabetes than those with type 2 diabetes.
PubMedID- 24687395 Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in china: a multicentre registration study.
PubMedID- 20633252 The authors conclude that future interventions should target both parental fear and appropriate ways to prevent hypoglycaemia in children with type 1 diabetes .
PubMedID- 20377657 In fact, there is nearly a threefold increase in hypoglycaemia with intensification of treatment in type 1 diabetes (1).
PubMedID- 22417321 Conclusions: rates of severe hypoglycaemia in youth with type 1 diabetes remain high.
PubMedID- 22175008 This pilot data suggests that gln supplementation increases the likelihood of postexercise overnight hypoglycaemia in adolescents with type 1 diabetes.
PubMedID- 20873363 Conclusions: insulin pump therapy has additional qualitative benefits beyond improvements in glycaemic control and reducing the risk of hypoglycaemia for people with type 1 diabetes.
PubMedID- 21493665 Conclusion: these two small crossover trials suggest that closed loop delivery of insulin may improve overnight control of glucose levels and reduce the risk of nocturnal hypoglycaemia in adults with type 1 diabetes.
PubMedID- 21737469 We selected for inclusion only studies that were randomised controlled trials and that compared glycaemic control and hypoglycaemia in participants with type 1 diabetes treated by intensive insulin therapy (multiple daily insulin injections or continuous subcutaneous insulin infusion) where either real time continuous glucose monitoring or self monitoring of blood glucose was used throughout the study for at least two months.
PubMedID- 25070348 Effects of angiotensin ii receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes.
PubMedID- 20854383 Fear of hypoglycaemia in adults with type 1 diabetes.
PubMedID- 25985748 Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
PubMedID- 24805141 Coeliac disease presenting as severe hypoglycaemia in youth with type 1 diabetes.
PubMedID- 20215476 Introduction: high renin-angiotensin system (ras) activity has been associated with a high risk of severe hypoglycaemia in patients with type 1 diabetes and with cognitive deterioration during experimental hypoglycaemia in healthy subjects.
PubMedID- 24185859 Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention.
PubMedID- 21812638 High serum ace activity predicts severe hypoglycaemia over time in patients with type 1 diabetes.
PubMedID- 21951030 Nph insulin based on the incidence of mild hypoglycaemia in subjects with type 1 diabetes in denmark, sweden, finland and the netherlands.
PubMedID- 25763988 Behavioural interventions targeting problem-solving skills could be considered as practical, non-pharmacological strategies to reduce hypoglycaemia in adolescents with type 1 diabetes.
PubMedID- 24654672 It has been estimated that the incidence rate for emergency treatment of severe hypoglycaemia in people with type 1 diabetes is ˜11.5 per 100 patients-years 11. in that study, the associated cost was estimated to be ˜£6.5 m across the uk.
PubMedID- 24123789 The beta-cell replacement by islet transplantation is an attractive approach for normalizing blood glucose without hypoglycaemia in patient with type 1 diabetes mellitus (t1d).
PubMedID- 24794703 Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (hypoana trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
PubMedID- 20546285 Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring.
PubMedID- 20121892 The results suggest that future interventions should target both the parents' fear and appropriate ways to prevent hypoglycaemia in children with type 1 diabetes.
PubMedID- 23821450 Rare cause of recurrent hypoglycaemia in type 1 diabetes mellitus--case 6/2013.
PubMedID- 23413806 The preservation of insulin secretion often seen for an initial period after diagnosis of type 1 diabetes is associated with reduced hypoglycaemia and glycaemic variability, improved hba1c and lower insulin requirements .
PubMedID- 25855340 Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
PubMedID- 26213236 Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with type 1 diabetes.
PubMedID- 26312919 Results from hospital-based studies have shown improved overnight glucose control and reduced risk of hypoglycaemia in type 1 diabetes.
PubMedID- 21188352 Melatonin decreases insulin sensitivity, can decrease insulin secretion and can increase blood glucose levels, while phototherapy sessions (which potentially decrease melatonin levels) have been shown to induce recurrent hypoglycaemia in a patient with type 1 diabetes .
PubMedID- 22258980 Diabetes complications, death and costs were not measured.there were no studies in pregnant women with diabetes type 1 and in patients with hypoglycaemia unawareness.

Page: 1